Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Immuneering Corp | Director | Class A Common Stock | 2.9K | $7.39K | $2.55 | Mar 22, 2024 | Direct |
Immuneering Corp | Director | Stock Option | 8.59K | Jun 12, 2024 | Direct | ||
ChemoCentryx, Inc. | President and CEO, Director | Common Stock | 0 | $50.95 | Oct 20, 2022 | Direct | |
ChemoCentryx, Inc. | President and CEO, Director | Restricted Stock Unit | 0 | Oct 20, 2022 | Direct | ||
ChemoCentryx, Inc. | President and CEO, Director | Stock Option | 0 | Oct 20, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
IMRX | Immuneering Corp | Jun 12, 2024 | 1 | $0 | 4 | Jun 13, 2024 | Director |
IMRX | Immuneering Corp | Mar 22, 2024 | 1 | $7.38K | 4 | Mar 25, 2024 | Director |
IMRX | Immuneering Corp | Mar 11, 2024 | 1 | $0 | 4 | Mar 12, 2024 | Director |
IMRX | Immuneering Corp | Mar 11, 2024 | 0 | $0 | 3 | Mar 12, 2024 | Director |
CCXI | ChemoCentryx, Inc. | Oct 20, 2022 | 20 | $0 | 4 | Oct 24, 2022 | President and CEO, Director |
CCXI | ChemoCentryx, Inc. | Aug 4, 2022 | 3 | -$4.68M | 4 | Aug 8, 2022 | President and CEO, Director |
CCXI | ChemoCentryx, Inc. | Feb 22, 2022 | 2 | $0 | 4 | Feb 25, 2022 | President and CEO, Director |
CCXI | ChemoCentryx, Inc. | Jan 1, 2022 | 7 | -$1.66M | 4 | Jan 4, 2022 | President and CEO, Director |
CCXI | ChemoCentryx, Inc. | Dec 1, 2021 | 4 | $500K | 4 | Dec 3, 2021 | President and CEO, Director |